115 Economic burden among migraine patients: United Kingdom perspective

• Published in: Journal of neurology, neurosurgery and psychiatry Vol. 90; no. 12; p. e34
• Main Authors: Martelletti, Paolo, Schwedt, Todd, Lanteri-Minet, Michel, Diener, Hans-Christoph, Torre, Elena Ruiz de la, Craven, Audrey, Evans, Simon, Walsh, Donna, Dumas, Paula, Laflamme, Annik
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group LTD 01-12-2019
• Subjects: Absenteeism; Migraine; Productivity; United Kingdom > UK
• ISSN: 0022-3050; 1468-330X
• DOI: 10.1136/jnnp-2019-ABN-2.113

ObjectivesAs part of the worldwide My Migraine Voice survey, this study evaluated the real-world healthcare resource utilization (HRU) and impact on work and activity impairment among people living with migraine in the United Kingdom (UK).MethodsAn analysis was conducted using UK subset data from My Migraine Voice survey: a worldwide, cross-sectional, online study including respondents (≥18 years), with ≥4 monthly migraine days, with 90% having used preventive migraine treatment in the preceding three months. HRU (Emergency room [ER] visits and hospitalisations) and impact of migraine on work and daily activities were evaluated and compared amongst different preventive treatment failure (TF) patient subgroups.ResultsOf the 690 respondents, 17% had visited ER (average 2.8 times/year), and 13% were hospitalised (average 3.0 days). Participants reported 13% missed working time (absenteeism), 52% reduction in productivity (presenteeism), and 58% reduction in both overall work productivity and daily activities due to migraine in last 7-days. HRU, absenteeism and presenteeism was higher in those with ≥2 TF vs patients with no TF.ConclusionThis study demonstrates the burden among patients with migraine in terms of HRU, work productivity loss, and activity impairment. The impact is increased in patients who have had ≥2 preventive treatment failures.